[Managing nausea and vomiting in thoracic oncology].
Nausea and vomiting are frequent symptoms that deteriorate the quality of life of lung cancer patients. They are most often iatrogenic and related to chemotherapy based on platinum salts; they can also be evidence of metastasis to the brain or hypercalcemia. Understanding the physiopathological mechanisms at work can make it possible to adopt effective therapeutic measures that are specific to each etiological context.
Le Moulec
S
S
Service d'Oncologie, Hôpital du Val-de-Grâce, 74 Boulevard de Port-Royal, 75005 Paris, France. sylvestre.lemoulec@club-internet.fr
Vedrine
L
L
D000932:Antiemetics / Q000009:adverse effects / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D009325:Nausea / Q000139:chemically induced / Q000628:therapy*; D009369:Neoplasms / Q000188:drug therapy / Q000503:physiopathology*; D010166:Palliative Care / Q000379:methods*; D012307:Risk Factors; D013727:Terminal Care / Q000379:methods; D014839:Vomiting / Q000139:chemically induced / Q000628:therapy*
D000932:Antiemetics; D000970:Antineoplastic Agents